GlassScriptPhysician profile
Khoi Vo
NPI 1265985501
$3,291.43
in general payments reported to CMS, 2019-2025
20 companies · $1,117 in 2025
The $1,117 reported for 2025 was more than what 82% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $71.61 · 2021: $724 · 2022: $554 · 2023: $254 · 2024: $91.98 · 2025: $1,117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $890 · Travel and Lodging: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $890.13 |
| Travel and Lodging | $572.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $1,030.66 | 2025 | Biobrace 23mm, Neospan, Quantum |
| Treace Medical Concepts, INC. | $1,029.86 | 2021-2025 | |
| Horizon Therapeutics Plc | $304.74 | 2019-2023 | Krystexxa |
| Smith+Nephew, INC. | $240.75 | 2019-2025 | Stravix Pl |
| Organogenesis INC. | $186.35 | 2019-2024 | |
| Bioventus LLC | $72.92 | 2019-2020 | |
| Nevro Corp. | $69.51 | 2022-2023 | Senza |
| Cumberland Pharmaceuticals, INC. | $51.12 | 2023-2024 | Caldolor |
| Paratek Pharmaceuticals, INC. | $47.10 | 2022-2024 | Nuzyra |
| Abbott Laboratories | $43.75 | 2022-2023 | Proclaim |
| Stryker Corporation | $40.42 | 2022 | |
| Osiris Therapeutics INC. | $34.08 | 2019 | |
| Mid-Atlantic Surgical Systems, LLC | $28.97 | 2023 | |
| Zimmer Biomet Holdings, INC. | $23.63 | 2019 | |
| Abbvie INC. | $17.83 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trice Medical, INC. | $15.52 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $15.23 | 2022 | |
| Amgen INC. | $14.47 | 2025 | Krystexxa |
| Kerecis Limited | $12.38 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $12.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khoi Vo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.